decisionhealth Newsletters, Answer Books - 2006 Issue 3 (March)
Program_Memos / 2001 / AB-01-66
Subscribe or sign in to view the full article.
Article Overview
This article is a Medicare Program Memorandum issued by HCFA/CMS that addresses implementation guidance related to the Benefits Improvement and Protection Act of 2000 for payment allowance of drugs and biologicals. It explains the scope and timing of the moratorium on reducing payment rates, and it situates the guidance within earlier program memoranda governing the established payment methodology and source data for average wholesale price. It is relevant to Medicare billing and reimbursement staff, carriers/intermediaries, and compliance teams tracking federal payment policy changes.
Why This Topic Matters
It clarifies how a temporary statutory moratorium affects Medicare payment allowance practices for drugs and biologicals and ties that requirement to existing HCFA guidance. Organizations responsible for Medicare claims processing need this context to remain aligned with current federal payment instructions and effective dates.
Article Sections
-
Program Memorandum and Subject
Identifies the issuing agency, transmittal information, date, and the overall subject of the memorandum.
-
Purpose and statutory background
Summarizes the purpose of the memorandum and places it in the context of BIPA-related Medicare payment provisions and related congressional review requirements.
-
Scope of Moratorium
Describes the general reach of the moratorium and its relationship to established payment methodology and source data considerations.
-
Instructions
Provides implementation guidance and references earlier program memoranda that remain applicable for the subject matter covered.
What You Will Learn
- How the memorandum fits into Medicare payment policy guidance for drugs and biologicals
- What general subject matter is covered by the BIPA-related moratorium
- How the article positions earlier HCFA program memoranda within the current guidance
- Which timing elements govern the memorandum's applicability and implementation
Who Should Read This
- Medicare carriers and intermediaries
- Billing and reimbursement staff
- Compliance and revenue cycle teams
- Healthcare policy analysts
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com